All China Stocks -All Information About China Stocks Traded In U.S. Stock Markets

All China Stocks

3SBio Inc. (SSRX)

2010-09-04 5:37:49 AM

Overall

★★★★

What's this

Target

Six months: 17.87 One year: 20.87

Support

Support1: 12.67 Support2: 11.05

Resistance

Resistance1: 15.30 Resistance2: 17.87

Pivot

12.89

Moving Averages

MA(5): 13.06 MA(20): 13.15

MA(100): 12.68 MA(250): 12.27

MACD

MACD(12,26): -0.17

Signal(12,26,9): -0.23

Stochastic Oscillator

%K(14,3): 63.65

%D(3): 50.34

RSI

RSI(14): 55.76

Financials:
EPS	0.620	EPS Est. Current Year	0.640
EPS Est. Next Quarter	0.090	EPS Est. Next Year	0.760
Forward EPS	0.760	Book Value (p.s.)	7.320
PEG Ratio	1.05	Profit Margin	25.15
Operating Margin	25.66	Return on Assets (ttm)	5.6
Return on Equity (ttm)	9.1	Qtrly Rev. Growth	29.5
Gross Profit (p.s.)	1.980	Sales Per Share	2.507
EBITDA (p.s.)	0.706	Qtrly Earnings Growth	-5.40
Operating Cash Flow (M)	0.00	Levered Free Cash Flow (M)	0.00
Statistics
Shares Out. (M)	21.58	Shares Float (M)	12.73
% Held by Insiders	0.00	% Held by Institutions	0.00
Shares Short (K)	156	SharesShort PriorMonth (K)	175
Valuation
P/E	21.89	P/E Growth Ratio	0.01
P/BV	1.85	P/S	5.41
P/CF	0.00	Dividend Yield	0.00
Stock Price History
52-Week High	15.30	52-Week Change (%)
52-Week Low	9.72	29.4

★ Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Business Description:

3SBio, Inc., a biotechnology company, focuses on the research, development, manufacture, and marketing of biopharmaceutical products primarily in the People's Republic of China. Its product candidates are designed to address unmet medical needs in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. The company's principal product, EPIAO is an injectable recombinant human erythropoietin that is used to stimulate the production of red blood cells in patients with anemia and to reduce the need for blood transfusions.

Address: No. 3 A1, Road 10, Shenyang Eco Tech Dvpmt Zone, Shenyang, CN

Sector: Healthcare

Industry: Drugs

Headline News